Manufacturer of Controlled Substances; Notice of Application, 48779 [05-16468]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 160 / Friday, August 19, 2005 / Notices
The Commission will transmit its
determination in this investigation to
the Secretary of Commerce on August
15, 2004. The views of the Commission
are contained in USITC Publication
3792 (August 2005), entitled Metal
Calendar Slides from Japan:
Investigation No. 731–TA–1094
(Preliminary).
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16468 Filed 8–18–05; 8:45 am]
By order of the Commission.
Issued: August 15, 2005.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05–16425 Filed 8–18–05; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on March 16,
2005, Abbott Laboratories, DBA Knoll
Pharmaceutical Company, 30 North
Jefferson Road, Whippany, New Jersey
07981, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Schedule
Dihydromorphine (9145) ...............
Hydromorphone (9150) ................
I
II
The company plans to manufacture
bulk product and dosage units for
distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
VerDate jul<14>2003
16:47 Aug 18, 2005
Jkt 205001
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on March 7,
2005, Lonza Riverside, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Schedule
Gamma
hydroxybutyric
acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
I
II
II
The company plans to manufacture
bulk products for finished dosage units
and distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16469 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
48779
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 29, 2005, and
published in the Federal Register on
April 6, 2005, (70 FR 17473), Polaroid
Corporation, 1265 Main Street, Building
W6, Waltham, Massachusetts 02454,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of 2,5Dimethoxyamphetamine (7396), a basic
class of controlled substance listed in
Schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for conversion into non-controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Polaroid Corporation to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Polaroid
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16466 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 70, Number 160 (Friday, August 19, 2005)]
[Notices]
[Page 48779]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16468]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 16, 2005, Abbott
Laboratories, DBA Knoll Pharmaceutical Company, 30 North Jefferson
Road, Whippany, New Jersey 07981, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dihydromorphine (9145)..................... I
Hydromorphone (9150)....................... II
------------------------------------------------------------------------
The company plans to manufacture bulk product and dosage units for
distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than October 18, 2005.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-16468 Filed 8-18-05; 8:45 am]
BILLING CODE 4410-09-P
